Inventor · disambiguated record
Peter Krammer
Also filed as: KRAEMMER PETER · KRAMMER PETER · KRAMMER PETER H
15 granted patents·15 pending applications·98 citations·filing 1986–2021
91Inventor score
Files withDEUTSCHES KREBSFORSCH11DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS4SIEMENS AG3LI-WEBER MIN2SENTEC AG2
Top patents by PatentIndex Score
30 records- 0177US4764905AUltrasonic transducer for the determination of the acoustic power of a focused ultrasonic fieldSIEMENS AG·Filed 1986·Granted Aug 16, 1988·34 cites·3 claims
- 0273US6721470B2Optical measurement device in a pressed-in conductor bar in an electrical machineSIEMENS AG·Filed 2002·Granted Apr 13, 2004·19 cites·15 claims
- 0367US6770474B2p53 binding areasDEUTSCHES KREBSFORSCH·Filed 2001·Granted Aug 3, 2004·2 cites·6 claims
- 0461US8563500B2Methods and compounds for treating diseases caused by reactive oxygen speciesGUELOW KARSTEN·Filed 2007·Granted Oct 22, 2013·2 cites·9 claims
- 0560US7935339B2Inhibition of the CD95 ligand/receptor system for the treatment of neurological disorders and injuriesDEUTSCHES KREBSFORSCH·Filed 2004·Granted May 3, 2011·3 cites·21 claims
- 0660US6696547B2Mutant DEDD proteins for regulating apoptosisDEUTSCHES KREBSFORSCH·Filed 2000·Granted Feb 24, 2004·1 cites·3 claims
- 0757USD906518SConnector for an electrical array of medical devicesSENTEC AG·Filed 2018·Granted Dec 29, 2020·7 cites·1 claims
- 0857US9387192B2Combination of rocaglamide and apoptosis inducing substances for the treatment of cancerLI-WEBER MIN·Filed 2009·Granted Jul 12, 2016·0 cites·12 claims
- 0955US11851463B2Core domain of annexins and uses thereof in antigen delivery and vaccinationDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2021·Granted Dec 26, 2023·0 cites·11 claims
- 1055US5891434AMonoclonal antibodies to the APO-1 antigenCENTOCOR INC·Filed 1995·Granted Apr 6, 1999·14 cites·11 claims
- 1153US10947283B2Core domain of annexins and uses thereof in antigen delivery and vaccinationDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2017·Granted Mar 16, 2021·0 cites·2 claims
- 1252US2021161851A1Combination therapy of lymphomaDEUTSCHES KREBSFORSCH·Filed 2020·Application pending·0 cites
- 1350US12329800B2Annexin-coated particlesDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2020·Granted Jun 17, 2025·0 cites·14 claims
- 1450US4725989AMethod controlling the focusing of an ultrasonic field and apparatus for performing said methodSIEMENS AG·Filed 1986·Granted Feb 16, 1988·11 cites·9 claims
- 1550US2015152169A1Inhibitors of thioredoxin-interacting protein (TXNIP) for therapyDEUTSCHES KREBSFORSCH·Filed 2013·Application pending·0 cites
- 1649US2016287553A1Translation inhibitors in high-dose chemo- and/or high-dose radiotherapyDEUTSCHES KREBSFORSCH·Filed 2014·Application pending·0 cites
- 1748US2007207160A1Apoptosis inhibitorsKRAMMER PETER·Filed 2007·Application pending·0 cites
- 1845US2016158189A1Sensitization of cancer cells to apoptosis induction by flavaglines and 5-hydroxy-flavonesDEUTSCHES KREBSFORSCH·Filed 2014·Application pending·0 cites
- 1944US2017002352A1Inhibitors of thioredoxin-interacting protein (TXNIP) for therapyDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTES·Filed 2016·Application pending·0 cites
- 2041US6485929B1Method for inhibiting CD95-independent apoptosis in AIDSDEUTSCHES KREBSFORSCH·Filed 1999·Granted Nov 26, 2002·5 cites·10 claims
- 2139US2014171624A1Modulators of adp-dependent glucokinase (adpgk) and glycerol-3-phosphate dehydrogenase (gpd2) for therapyDEUTSCHES KREBSFORSCH·Filed 2013·Application pending·0 cites
- 2239US2020385738A1H-1 pv expressing rnai effectors targeting cdk9DEUTSCHES KREBSFORSCH·Filed 2017·Application pending·0 cites
- 2337US11793418B2Sensor belt and positioning aid for electro-impedance tomography imaging in neonatesSENTEC AG·Filed 2017·Granted Oct 24, 2023·0 cites·25 claims
- 2437US2018169123A1Combination therapy with a flavagline and 2-deoxyglucoseUNIV HEIDELBERG RUPRECHT KARLS·Filed 2016·Application pending·0 cites
- 2535US2015038955A1Skin contact detecting device for a device to be securedPANTEC BIOSOLUTIONS AG·Filed 2012·Application pending·0 cites
- 2633US2018275124A1Modulators of the function of the core domain of annexins, and uses thereof in autoimmune and/or cancer therapyDEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS·Filed 2015·Application pending·0 cites
- 2733US2003082180A1Combination of compounds that inhibit the biological effects of tnf-alpha and cd95l in a medicamentFiled 2000·Application pending·0 cites
- 2833US2016374983A1Combination of rocaglamide and apoptosis inducing substances for the treatment of cancerLI-WEBER MIN·Filed 2016·Application pending·0 cites
- 2931US2003157502A1Chemotherapeutant screening methodFiled 2000·Application pending·0 cites
- 3031US2016113958A1Modulators of adp-dependent glucokinase (adpgk) and glycerol-3-phosphate dehydrogenase (gpd2) for therapyDEUTSCHES KREBSFORSCH·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Peter Krammer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →